What causes low UIBC?

Low UIBC (Unsaturated Iron-Binding Capacity) typically indicates iron overload conditions like hemochromatosis, liver disease, or excessive iron supplementation. It can also result from inflammation, certain cancers, or kidney disease that affect how your body processes and stores iron.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding UIBC and Its Role in Iron Metabolism

Unsaturated Iron-Binding Capacity (UIBC) is a crucial blood test that measures how much transferrin in your blood is available to bind and transport iron. Transferrin is the primary protein responsible for carrying iron throughout your body, delivering it where it's needed for essential functions like making red blood cells and supporting cellular metabolism.

When UIBC is low, it means that most of your transferrin is already saturated with iron, leaving little capacity to bind additional iron. This typically indicates that your body has more iron than it can safely manage, which can lead to iron accumulation in organs and tissues. Understanding your UIBC levels, along with other iron markers, provides valuable insights into your overall iron status and metabolic health.

How UIBC Works in Your Body

Think of transferrin as a fleet of delivery trucks and iron as the cargo. UIBC tells you how many empty trucks are available. When UIBC is low, most trucks are already full, suggesting your body has plenty of iron—perhaps too much. This measurement works alongside other iron tests like serum iron, ferritin, and Total Iron-Binding Capacity (TIBC) to provide a complete picture of your iron metabolism.

Iron Study Reference Ranges and Interpretation

Iron studies should be interpreted together for accurate diagnosis. Ranges may vary by laboratory.
TestNormal RangeLow UIBC PatternClinical Significance
UIBCUIBC150-375 mcg/dL<150 mcg/dLIndicates reduced iron-binding capacity
Serum IronSerum Iron60-170 mcg/dLOften elevatedAmount of iron in blood
TIBCTIBC250-450 mcg/dLNormal or lowTotal binding capacity
Transferrin SaturationTransferrin Saturation20-50%Often >50%Percentage of transferrin bound to iron
FerritinFerritin12-300 ng/mLOften elevatedIron storage marker

Iron studies should be interpreted together for accurate diagnosis. Ranges may vary by laboratory.

Normal UIBC Ranges

Normal UIBC levels typically range from 150 to 375 mcg/dL, though these values can vary slightly between laboratories. Low UIBC is generally considered to be below 150 mcg/dL. However, UIBC should always be interpreted in conjunction with other iron studies for accurate assessment.

Primary Causes of Low UIBC

Iron Overload Conditions

The most common cause of persistently low UIBC is iron overload. This occurs when your body accumulates more iron than it can use or safely store. Primary hemochromatosis, a genetic disorder affecting iron absorption, is a leading cause. In this condition, your intestines absorb too much iron from food, leading to dangerous accumulation in organs like the liver, heart, and pancreas.

Secondary iron overload can result from repeated blood transfusions, excessive iron supplementation, or certain types of anemia that require frequent iron therapy. People receiving treatment for conditions like thalassemia or sickle cell disease may develop iron overload over time, reflected in their low UIBC levels.

Liver Disease and Dysfunction

Your liver plays a central role in iron metabolism and transferrin production. When liver function is compromised, it can lead to low UIBC through multiple mechanisms. Chronic liver diseases like cirrhosis, hepatitis, or fatty liver disease can impair the liver's ability to produce transferrin, resulting in less overall iron-binding capacity.

Additionally, liver damage can disrupt the normal regulation of iron storage and release, leading to inappropriate iron accumulation. This creates a cycle where liver disease causes iron buildup, which further damages the liver. Regular monitoring of liver function alongside iron studies is essential for managing these interconnected conditions.

Medical Conditions Associated with Low UIBC

Inflammatory and Chronic Diseases

Chronic inflammation can significantly impact iron metabolism and UIBC levels. Conditions like rheumatoid arthritis, inflammatory bowel disease, and chronic infections trigger the release of inflammatory proteins that alter how your body handles iron. These proteins, particularly hepcidin, can trap iron in storage sites and reduce transferrin production, leading to low UIBC despite potentially normal or even low total body iron.

This phenomenon, known as anemia of chronic disease or anemia of inflammation, represents a complex interplay between your immune system and iron metabolism. The body essentially hides iron from potential pathogens as a protective mechanism, but this can result in functional iron deficiency even when storage iron is adequate.

Kidney Disease

Chronic kidney disease can cause low UIBC through several pathways. The kidneys help regulate iron metabolism and produce erythropoietin, a hormone that stimulates red blood cell production. When kidney function declines, this delicate balance is disrupted. Additionally, many kidney disease patients require iron supplementation or receive it through dialysis, which can contribute to iron overload over time.

Certain Cancers

Some cancers, particularly those affecting the blood or bone marrow like leukemia or multiple myeloma, can cause low UIBC. These cancers may interfere with normal iron metabolism, increase iron utilization, or affect the production of transferrin. Additionally, cancer-related inflammation can contribute to altered iron handling, similar to other chronic inflammatory conditions.

Symptoms and Health Implications of Low UIBC

Low UIBC itself doesn't cause symptoms, but the underlying conditions responsible for it certainly can. When low UIBC indicates iron overload, you might experience fatigue, joint pain, abdominal discomfort, and skin color changes (often a bronze or gray tint). Men may notice decreased libido or erectile dysfunction, while women might experience irregular periods.

The long-term consequences of untreated iron overload can be severe. Excess iron acts as a toxin, generating harmful free radicals that damage cells and organs. This can lead to cirrhosis, heart failure, diabetes, and arthritis. Early detection through comprehensive iron testing allows for intervention before permanent organ damage occurs.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Approach and Testing

Diagnosing the cause of low UIBC requires a comprehensive approach. Your healthcare provider will typically order a complete iron panel including serum iron, TIBC, ferritin, and transferrin saturation. These tests work together to reveal whether low UIBC indicates true iron overload or is secondary to inflammation or other conditions.

Additional testing might include liver function tests, inflammatory markers like C-reactive protein, and genetic testing for hereditary hemochromatosis if suspected. In some cases, imaging studies or liver biopsy may be necessary to assess iron deposition in organs. The key is to identify the underlying cause rather than just treating the laboratory abnormality.

Treatment Strategies for Low UIBC

Managing Iron Overload

When low UIBC results from iron overload, treatment focuses on reducing body iron stores. Therapeutic phlebotomy (regular blood removal) remains the gold standard for hereditary hemochromatosis and many other iron overload conditions. Initially, you might need weekly phlebotomy sessions until iron levels normalize, followed by maintenance treatments every few months.

For patients who cannot tolerate phlebotomy, iron chelation therapy provides an alternative. These medications bind excess iron and help your body excrete it through urine or stool. Dietary modifications, including limiting iron-rich foods and avoiding vitamin C supplements with meals (which enhance iron absorption), also play a supporting role.

Addressing Underlying Conditions

When low UIBC stems from liver disease, inflammation, or other medical conditions, treatment must target the root cause. This might involve antiviral therapy for hepatitis, immunosuppressive medications for autoimmune conditions, or lifestyle modifications for fatty liver disease. As the underlying condition improves, UIBC levels often normalize.

Prevention and Monitoring

Preventing low UIBC largely involves avoiding unnecessary iron supplementation and maintaining overall health. Unless you have documented iron deficiency, avoid iron supplements without medical supervision. Be particularly cautious with multivitamins containing iron, as many people consume these without realizing they're adding to their iron burden.

Regular monitoring is crucial, especially if you have risk factors for iron overload or conditions affecting iron metabolism. Annual iron studies can catch problems early, when they're most treatable. If you have a family history of hemochromatosis or unexplained liver disease, genetic testing and more frequent monitoring may be warranted.

Living with Low UIBC: Practical Considerations

Managing low UIBC often requires lifestyle adjustments. If you have iron overload, you'll need to be mindful of your diet, limiting red meat and iron-fortified foods while increasing consumption of foods that inhibit iron absorption, like tea and coffee with meals. Regular exercise helps improve insulin sensitivity and overall metabolic health, which can be compromised by iron overload.

Communication with healthcare providers is essential. Always inform new doctors about your iron status, as many medications and supplements can affect iron metabolism. If you require surgery, your surgeon should know about any iron overload, as it can affect healing and increase infection risk. Building a comprehensive care team that understands your condition ensures better long-term outcomes.

References

  1. Adams, P. C., & Barton, J. C. (2023). Hemochromatosis and iron overload: Diagnosis and management. American Journal of Hematology, 98(4), 512-528.[Link][DOI]
  2. Camaschella, C., Nai, A., & Silvestri, L. (2020). Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica, 105(2), 260-272.[Link][PubMed][DOI]
  3. Brissot, P., Troadec, M. B., Loréal, O., & Brissot, E. (2019). Pathophysiology and classification of iron overload diseases; update 2018. Transfusion Clinique et Biologique, 26(1), 80-88.[PubMed][DOI]
  4. Girelli, D., Busti, F., Brissot, P., Cabantchik, I., Muckenthaler, M. U., & Porto, G. (2022). Hemochromatosis classification: Update and recommendations by the BIOIRON Society. Blood, 139(20), 3018-3029.[Link][PubMed][DOI]
  5. Weiss, G., Ganz, T., & Goodnough, L. T. (2019). Anemia of inflammation. Blood, 133(1), 40-50.[Link][PubMed][DOI]
  6. Kowdley, K. V., Brown, K. E., Ahn, J., & Sundaram, V. (2019). ACG Clinical Guideline: Hereditary Hemochromatosis. American Journal of Gastroenterology, 114(8), 1202-1218.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my UIBC at home?

While UIBC isn't included in standard at-home panels, you can test related iron markers like ferritin with SiPhox Health's Core Health Program, which includes ferritin testing. For comprehensive iron studies including UIBC, consult with your healthcare provider about specialized testing options.

What's the difference between low UIBC and high ferritin?

Low UIBC indicates reduced capacity to bind iron (full transferrin), while high ferritin shows increased iron storage. Both often occur together in iron overload conditions, but ferritin can also be elevated due to inflammation even when total body iron is normal.

Can diet alone fix low UIBC?

Diet modifications can help manage mild iron overload, but most cases of significantly low UIBC require medical treatment. Avoiding iron-rich foods and supplements is important, but conditions like hemochromatosis typically need phlebotomy or chelation therapy.

How often should I retest UIBC if it's low?

Testing frequency depends on the underlying cause and treatment. During active treatment for iron overload, testing might occur monthly. Once stable, testing every 3-6 months is typical. Your doctor will determine the appropriate schedule based on your specific condition.

Are there any medications that can cause low UIBC?

Yes, certain medications can contribute to low UIBC, including oral contraceptives, testosterone replacement therapy, and some chemotherapy drugs. Long-term use of iron supplements without medical supervision is a common cause of iatrogenic iron overload.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details